Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR

AIM: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. MATERIALS & METHODS: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamese, Murat, Ozgur, Didem, Tarhan, Ceyda, Altintas, Susamber D, Caliskan, Okan, Tuna, Aysegul, Kazci, Saliha, Karadavut, Mursel, Gumus, Abdullah, Apaydin, Gozde, Mumcu, Necati, Coruh, Onur, Tutuncu, Emin E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279024/
https://www.ncbi.nlm.nih.gov/pubmed/34223786
http://dx.doi.org/10.2217/fmb-2020-0134
Descripción
Sumario:AIM: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. MATERIALS & METHODS: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 in three neighbor cities located in the East of Turkey. The final study population was 7853 cases, after excluding screening tests. RESULTS: Real-time PCR was performed to detect the SARS-CoV-2-specific RNA-dependent-RNA-polymerase gene fragment. The number of total positive samples out of 7853 were 487; however, the number of nonrepeating positive patient was 373 (4.8%). Cough and fever were the most common symptoms in positive cases. CONCLUSION: Epidemiologic studies should be performed about the prevalence of SARS-CoV-2 infection to better understand the effect of the virus across the world.

Ejemplares similares